TB Report
📝 Submit Report
1
Basic Info
2
New PTB+
3
P/Neg & EPTB
4
Relapse & Re-Tx
5
Populations & Outcomes
6
Contacts & TPT
7
Molecular & DST
8
DR-TB Treatment
9
Malnutrition & TB/HIV
10
Leprosy & Lab

Step 1 — Basic Information

Select the reporting department, month, and year before proceeding.

Step 2 — New Bacteriologically Confirmed Pulmonary TB

All new PTB+ cases detected and enrolled this reporting period by age and sex.

PTB+Number of bacteriologically confirmed New Pulmonary TB cases detected & enrolled — by age & sex
Age GroupMaleFemale
0 – 4 years
5 – 9 years
10 – 14 years
15 – 19 years
20 – 24 years
25 – 34 years
35 – 44 years
45 – 54 years
55 – 64 years
≥ 65 years

Step 3 — Clinically Diagnosed P/Neg & New EPTB Cases

Both sub-sections by age and sex.

P/NegNumber of clinically diagnosed new pulmonary negative TB cases — by age & sex
Age GroupMaleFemale
0 – 4 years
5 – 9 years
10 – 14 years
15 – 19 years
20 – 24 years
25 – 34 years
35 – 44 years
45 – 54 years
55 – 64 years
≥ 65 years
EPTBNumber of clinically diagnosed & bacteriologically confirmed new EPTB cases — by age & sex
Age GroupMaleFemale
0 – 4 years
5 – 9 years
10 – 14 years
15 – 19 years
20 – 24 years
25 – 34 years
35 – 44 years
45 – 54 years
55 – 64 years
≥ 65 years

Step 4 — Relapse TB Cases & Re-treatment

RelapseNumber of all RELAPSE TB cases — by age & sex
Age GroupMaleFemale
0 – 4 years
5 – 9 years
10 – 14 years
15 – 19 years
20 – 24 years
25 – 34 years
35 – 44 years
45 – 54 years
55 – 64 years
≥ 65 years
Re-TxTuberculosis Re-treatment cases

Step 5 — Key Populations & TB Treatment Outcomes

PopulationsNumber of notified TB cases from key affected population groups
OutcomesTreatment outcome — cohort of new bacteriologically confirmed PTB+ cases (same month previous EFY)
P/Neg OutcomesTreatment outcome — cohort of clinically diagnosed pulmonary TB (P/Neg)
EPTB OutcomesTreatment outcome — cohort of new EPTB cases
Relapse OutcomesTreatment outcome — cohort of all Relapse cases
OtherCommunity referral, HEW & PPM

Step 6 — Contact Investigation & TPT Coverage

DS-TB ContactsContacts with index bacteriologically confirmed pulmonary DS-TB cases — by age
DR-TB ContactsContacts with index bacteriologically confirmed DR-TB cases — by age
ScreenedContacts screened for TB & screened negative — by age
Age GroupDS-TB Contacts ScreenedDR-TB Contacts ScreenedDS-TB Screened Negative
0 – 4 years
5 – 14 years
≥ 15 years
TPT NewContacts screened negative and put on TPT — by age & regimen
TPT CohortCohort of individuals started TPT 12 months prior — by age & regimen
TPT CompletionCohort of individuals completed TPT (started 12 months prior) — by age & regimen

Step 7 — Molecular Testing, DST & DR-TB Cases Detected

MolecularNew & relapse TB patients initially tested using WHO recommended molecular rapid tests — by age & sex
Age GroupMaleFemale
0 – 4 years
5 – 14 years
≥ 15 years
DST EvaluatedBacteriologically confirmed TB cases evaluated for drug susceptibility testing
DST ResultTB cases with DST result for at least rifampicin
HR-TBNumber of Hr-TB cases — by age & sex
Age GroupMaleFemale
< 15 years
≥ 15 years
RR/MDR/Pre-XDR/XDRConfirmed DR-TB cases — by type, age & sex
Type / AgeMaleFemale
RR only <15
RR only ≥15
MDR-TB <15
MDR-TB ≥15
Pre-XDR <15
Pre-XDR ≥15
XDR-TB <15
XDR-TB ≥15
FQ DSTDR-TB cases with DST result for fluoroquinolone

Step 8 — DR-TB Treatment Coverage & Outcomes

Initiating CentreIs the health facility a DR-TB Treatment initiating center?
Hr-TB RegimenNumber of Hr-TB put on Hr-TB regimen — by HIV status & registration group
2nd LineDR-TB cases put on 2nd line treatment — by regimen, HIV status & registration group
Interim 12moDR-TB Interim results — cohort initiated 12 months prior (same month previous year)

Short-term regimen cohort results (12 months):

Long-term regimen cohort results (12 months):

Final 24–36moDR-TB final outcomes — cohort started 24/36 months earlier

Short-term regimen cohort — 24 months earlier:

Long-term regimen cohort — 24 months earlier:

Long-term cohort (standardized + individualized) — 36 months earlier:

Step 9 — Malnutrition Screening & TB/HIV Co-infection

MalnutritionMalnutrition screening for DS-TB & DR-TB cases
CategoryNormalMAMSAM
DS-TB cases screened
DR-TB cases screened
TB/HIV+New & relapse TB patients with documented HIV positive result — by age & sex
Age GroupMaleFemale
< 15 years
≥ 15 years
TB/HIV-New & relapse TB patients with documented HIV negative result — by age & sex
Age GroupMaleFemale
< 15 years
≥ 15 years
On ARTHIV-positive new & relapse TB patients already on ART — by age & sex
Age GroupMaleFemale
0 – 4 years
5 – 14 years
≥ 15 years
New ARTNewly tested HIV positive TB patients who began ART — by age & sex
Age GroupMaleFemale
0 – 4 years
5 – 14 years
≥ 15 years

Step 10 — Leprosy, AFB & GeneXpert / LF-LAM

Complete all remaining fields then submit the report.

Leprosy NewNew leprosy cases detected (MB + PB)

New PB cases:

AgeMaleFemale
<15 years
≥15 years

New MB cases:

AgeMaleFemale
<15 years
≥15 years
Leprosy OtherRelapse, retreatment & contacts
Grade IINew leprosy cases with Grade II disability (MB+PB) — by age & sex
AgeMaleFemale
<15 years
≥15 years
Leprosy CohortTreatment completion — new leprosy cohort registered 16 months prior
AFBTotal AFB tests performed & positive — by method
GeneXpertTotal GeneXpert MTB/RIF/Ultra tests for MTB detection
LF-LAMLF-LAM assay tests